Intervju med vd Peter Zerhouni från InDex Pharmaceuticals

Research Interview

2017-06-27

10:16

Mathias Spinnars intervjuar InDex Pharmaceuticals vd Peter Zerhouni om att den första patienten har inkluderats i fas IIb CONDUCT.

MS

Mathias Spinnars

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.